Liposic

Carbomer, the active ingredient in Liposic, is an excipient presented as a gel‑forming agent for ocular use. It acts as a viscosity enhancer, creating a stable, lubricating matrix that prolongs drug residence time on the eye surface and supports comfortable administration.

GNH USA supplies Liposic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable logistics for bulk and unit‑dose requirements. The company also offers regulatory support and documentation for import across regions.

Liposic, containing carbomer, is employed as a viscosity‑enhancing excipient in ophthalmic formulations to improve ocular surface comfort. - Dry eye syndrome: provides prolonged lubrication and reduces tear evaporation. - Post‑operative eye care: maintains drug contact time after ocular surgery, supporting healing. - Contact lens wear: stabilizes tear film and alleviates discomfort during lens use. - Allergic conjunctivitis: helps retain antihistamine agents on the ocular surface for better symptom control. - Ocular drug delivery: serves as a gel matrix to facilitate sustained release of active pharmaceuticals.

Carbomer‑based ophthalmic products are generally well tolerated, but local ocular reactions can occur.

Common Side Effects: - Transient ocular irritation: mild burning or stinging upon instillation. - Temporary blurred vision: visual acuity may be briefly reduced. - Tear film disturbance: occasional increased tearing. - Foreign body sensation: feeling of grit in the eye. - Mild redness: slight conjunctival hyperemia. - Temporary discomfort: brief sensation of heaviness.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, redness, or hives requiring medical attention. - Corneal ulceration: rare but serious ocular surface damage. - Infection risk: rare microbial contamination leading to keratitis. - Persistent inflammation: prolonged ocular redness or pain. - Vision loss: extremely rare, associated with severe corneal involvement. - Anaphylaxis: life‑threatening systemic reaction, though exceedingly uncommon.

When using Liposic, consider the following safety measures. - Assess patient history: verify no known allergy to carbomer or related polymers. - Monitor ocular response: observe for irritation or redness after first application. - Use with caution in compromised corneas: patients with epithelial defects may experience increased discomfort. - Avoid concurrent use with preservative‑rich drops: may increase irritation potential. - Discontinue if severe reaction occurs: seek ophthalmologic evaluation promptly. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Carbomer may interact with other ophthalmic products, affecting tolerability or formulation stability.

Major Interactions (Avoid): - Co‑administration with high‑concentration preservative eye drops: can exacerbate ocular irritation. - Mixing with acidic solutions: may destabilize the gel matrix.

Moderate Interactions (Monitor Closely): - Use with other viscous gels: may alter drug distribution and viscosity. - Concurrent use of contact lens solutions containing surfactants: could affect lens comfort. - Application before intraocular procedures: may interfere with surgical field clarity.